...
首页> 外文期刊>Kidney international. >Overexpression of ecto-5[prime]-nucleotidase promotes P-glycoprotein expression in renal epithelial cells
【24h】

Overexpression of ecto-5[prime]-nucleotidase promotes P-glycoprotein expression in renal epithelial cells

机译:ecto-5 [prime]-核苷酸酶的过表达促进肾上皮细胞中P-糖蛋白的表达

获取原文
           

摘要

Overexpression of ecto-5'-nucleotidase promotes P-glycoprotein expression in renal epithelial cells. P-glycoprotein (P-gp), responsible for multidrug resistance (MDR) of tumoral cells, is also expressed in apical membranes of normal epithelial cells, among which are proximal tubular cells. Ecto-5'-nucleotidase (5'Nu), co-located with P-gp in renal brush border membranes, could be instrumental in the expression of MDR phenotype. P-gp activity [assessed by rhodamine 123 (R123) and [3H]vinblastine (3H-VBL) accumulation] was evaluated in MDCK cell lines in which human 5'Nu was expressed at different levels after retroviral infection: MDCK-5'NU/- cells with a low 5'Nu activity (Vmax max 150 18.5 pmol/mg protein/min). MDCK-5'NU/- cells did not display functional expression of MDR. In MDCK-5'NU/+ cells, R123 and 3H-VBL accumulation was significantly lower than in MDCK-5'NU/- cells and was dramatically enhanced by P-gp inhibitors. This high P-gp activity in MDCK-5'NU/+ cells was confirmed by their resistance to colchicine (measured by LDH release and MTT assay) as compared to MDCK-5'NU/- and was accounted for by increased membrane expression of P-gp assessed by Western blot. Neither AMP nor adenosine, the substrate and the product of 5'Nu, respectively, affected P-gp activity. Inhibition of 5'Nu with -methylene-adenosine-diphosphate (MADP) or with a blocking anti-5'Nu antibody (1E9) did not blunt MDR expression in MDCK-5'NU/+ cells. Conversely, the anti-5'Nu antibody 5F/F9, which did not block the enzymatic site, induced a decrease of P-gp activity. Further, incubation of MDCK-5'NU/- cells with conditioned medium from MDCK-5'NU/+ cells, which contained significant amounts of released 5'Nu, induced MDR phenotype. In conclusion: (i) expression of ecto-5'Nu promotes multidrug resistance (MDR) activity in renal epithelial cells by enhancement of P-gp expression; (ii) this effect does not involve enzymatic activity of 5'Nu; (iii) supernatants of cells that express 5'Nu confered P-gp activity to 5'Nu negative cells.
机译:ecto-5'-核苷酸酶的过表达促进肾上皮细胞中P-糖蛋白的表达。负责肿瘤细胞多药耐药性(MDR)的P-糖蛋白(P-gp)也表达在正常上皮细胞的顶膜中,其中包括近端肾小管细胞。 Ecto-5'核苷酸酶(5'Nu)与P-gp共同位于肾刷缘膜上,可能有助于MDR表型的表达。在MDCK细胞系中评估了P-gp活性[由若丹明123(R123)和[3H]长春碱(3H-VBL)积累评估],其中人5'Nu在逆转录病毒感染后以不同水平表达:MDCK-5'NU 5-Nu活性低的细胞(Vmax最大值150 18.5 pmol / mg蛋白质/分钟)。 MDCK-5'NU /-细胞不显示MDR的功能性表达。在MDCK-5'NU / +细胞中,R123和3H-VBL的积累显着低于MDCK-5'NU /-细胞,并且被P-gp抑制剂显着增强。与MDCK-5'NU /-相比,MDCK-5'NU / +细胞中的这种高P-gp活性通过其对秋水仙碱的抗性(通过LDH释放和MTT分析测量)得到证实,这是由于MDCK-5'NU / +细胞的膜表达增加所致。通过蛋白质印迹评估P-gp。 AMP和腺苷,5'Nu的底物和产物均不影响P-gp活性。用-亚甲基-腺苷二磷酸(MADP)或用抗性5'Nu抗体(1E9)抑制5'Nu不会使MDCK-5'NU / +细胞中的MDR表达减弱。相反,未阻断酶促位点的抗5'Nu抗体5F / F9导致P-gp活性降低。此外,将MDCK-5'NU /-细胞与来自含有大量释放的5'Nu的MDCK-5'NU / +细胞的条件培养基一起孵育,诱导了MDR表型。结论:(i)ecto-5'Nu的表达通过增强P-gp的表达促进肾上皮细胞的多药抗性(MDR)活性; (ii)该作用不涉及5'Nu的酶活性; (iii)表达5'Nu的细胞的上清液赋予5'Nu阴性细胞P-gp活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号